MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/alz.14243

Медицинская библиотека · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024

Deletion of miR-33, a regulator of the ABCA1-APOE pathway, ameliorates neuropathological phenotypes in APP/PS1 mice.

Tate Mason, Wijeratne H R Sagara, Kim Byungwook, Philtjens Stéphanie, You Yanwen, Lee Do-Hun, Gutierrez Daniela A, Sharify Daniel, Wells Megan, Perez-Cardelo Magdalena, Doud Emma H, Fernandez-Hernando Carlos, Lasagna-Reeves Cristian, Mosley Amber L, Kim Jungsu

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

INTRODUCTION

Rare variants in ABCA1 increase the risk of developing Alzheimer's disease (AD). ABCA1 facilitates the lipidation of apolipoprotein E (apoE). This study investigated whether microRNA-33 (miR-33)-mediated regulation of this ABCA1-APOE pathway affects phenotypes of an amyloid mouse model.

METHODS

We generated mir-33+/+;APP/PS1 and mir-33-/-;APP/PS1 mice to determine changes in amyloid pathology using biochemical and histological analyses. We used RNA sequencing and mass spectrometry to identify the transcriptomic and proteomic changes between our genotypes. We also performed mechanistic experiments by determining the role of miR-33 in microglial migration and amyloid beta (Aβ) phagocytosis.

RESULTS

Mir-33 deletion increases ABCA1 levels and reduces Aβ accumulation and glial activation. Multi-omics studies suggested miR-33 regulates the activation and migration of microglia. We confirm that the inhibition of miR-33 significantly increases microglial migration and Aβ phagocytosis.

DISCUSSION: These results suggest that miR-33 might be a potential drug target by modulating ABCA1 level, apoE lipidation, Aβ level, and microglial function.

HIGHLIGHTS: Loss of microRNA-33 (miR-33) increased ABCA1 protein levels and the lipidation of apolipoprotein E. Loss of miR-33 reduced amyloid beta (Aβ) levels, plaque deposition, and gliosis. mRNAs and proteins dysregulated by miR-33 loss relate to microglia and Alzheimer's disease. Inhibition of miR-33 increased microglial migration and Aβ phagocytosis in vitro.

Для цитирования: Tate Mason, Wijeratne H R Sagara, Kim Byungwook, Philtjens Stéphanie, You Yanwen, Lee Do-Hun, Gutierrez Daniela A, Sharify Daniel, Wells Megan, Perez-Cardelo Magdalena, Doud Emma H, Fernandez-Hernando Carlos, Lasagna-Reeves Cristian, Mosley Amber L, Kim Jungsu. Deletion of miR-33, a regulator of the ABCA1-APOE pathway, ameliorates neuropathological phenotypes in APP/PS1 mice.. Alzheimer's & dementia : the journal of the Alzheimer's Association. 2024. DOI: 10.1002/alz.14243.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.